If you're new here, you may want to subscribe to my RSS feed. Thanks for visiting!
Vivien Didier, Canadian Health Ministry spokesman, stated yesterday on Canadian television that both houses of Parliament are reviewing the National Immunization Strategy (NIS) initiative to make Meningitis and Hepatisis A vaccination obligatory in all Canadian public and private schools.
The National Immunization Strategy has assisted the vaccination program planning in Canada Since 2003, pursuiting the idea that immunization issues must always be on the forefront of the Canadian public health agenda. This initiative is also backed and lobbied by Canada’s largest preventable diseases vaccination company- Sanofi Pasteur, developers of various well-known immunization shots like Adacel, Vivaxim, Menactra or Immucyst.
Toronto Star’s articles assess the probability of NIS to be endorsed as “reasonably high”. Political reviewers expect the initiative to be approved in the first reading, with having no exact financing figures for it specified. The initiative is to be discussed in Ottawa in the first week of May. If approved, it may go in effect in September 2008, just with the new schoolyear.
Canada’s largest vaccination company Sanofi Pasteur launches the new pertussis immunization vaccine for workplace and home protection, called Adacel. May is scheduled to be the time, when it goes out to general use. Adacel goes alongside with Sanofi Pasteur’s newest workplace influenza shot and will provide guaranteed protection to Canadians during cold and frosty northern winters.
Sanofi Pasteur is a true innovator in the sphere of Canadian medical treatment. Last year it shook the pharma market with innovative BCG cancer treatment medicines and handy travel diarrhea remedies. During the last two years Sanofi Pasteur dramatically extended its line of previously purely vaccination products targeted against dozens of preventable diseases such as diphtheria, polio, meningitis, tetanus, influenza, acellular Pertussis and more.
Sanofi Pasteur was originally founded as the preventable diseases vaccines business of the Sanofi-Aventis Group, the third largest pharmaceutical company in the world.

